Literature DB >> 35879469

The antenatal sildenafil STRIDER trial for severe fetal growth restriction, are post hoc reflections ad rem?

Francesca M Russo1,2, Felix R De Bie3, Emily A Partridge4, Karel Allegaert5,6,7, Jan Deprest3,8,9.   

Abstract

Entities:  

Year:  2022        PMID： 35879469     DOI： 10.1007/s00431-022-04569-7

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN： 0340-6199            Impact factor:   3.860


× No keyword cloud information.
  1 in total

1.  STRIDER NZAus: a multicentre randomised controlled trial of sildenafil therapy in early-onset fetal growth restriction.

Authors:  K M Groom; L M McCowan; L K Mackay; A C Lee; G Gardener; J Unterscheider; R Sekar; J E Dickinson; P Muller; R A Reid; D Watson; A Welsh; J Marlow; S P Walker; J Hyett; J Morris; P R Stone; P N Baker
Journal:  BJOG       Date:  2019-03-14       Impact factor: 6.531
  1 in total
  2 in total

1.  Pharmacotherapy during Pregnancy, Childbirth, and Lactation.

Authors:  Karel Allegaert
Journal:  Int J Environ Res Public Health       Date:  2022-09-09       Impact factor: 4.614

Review 2.  Sildenafil during the 2nd and 3rd Trimester of Pregnancy: Trials and Tribulations.

Authors:  Felix Rafael De Bie; David Basurto; Sailesh Kumar; Jan Deprest; Francesca Maria Russo
Journal:  Int J Environ Res Public Health       Date:  2022-09-06       Impact factor: 4.614
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.